Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck-Schering Doesn't Look So Good
Motley Fool
Saturday, October 24, 2009 - 10:48am
tags:
Merck, Schering Plough
Myriad Pharmaceuticals' Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R)
Yahoo/Global News Wire
Saturday, October 24, 2009 - 10:46am
tags:
Myriad, Azixa, Avastin, brain cancer
Not 50% Growth, but We'll Take It (Celgene)
Motley Fool
Saturday, October 24, 2009 - 10:45am
tags:
Celgene, Revlimid
Isis Diabetes Drug Shows Promise
Yahoo/Zacks.com
Friday, October 23, 2009 - 12:00pm
tags:
diabetes, Isis Pharmaceuticals
Dr. Reddy’s Profit Doubles on Sales in U.S., Russia
Bloomberg
Friday, October 23, 2009 - 11:33am
tags:
Dr Reddy's, earnings, India
Biogen, Elan Fall as Tysabri Brain Disease Cases Rise
Bloomberg
Friday, October 23, 2009 - 11:29am
tags:
Tysabri, PML, Elan, Biogen Idec
FDA reviews Human Genome's anthrax medication
Yahoo/AP
Friday, October 23, 2009 - 11:26am
tags:
Human Genome Sciences, anthrax, FDA, ABthrax
Pfizer rejoins pharma stampede to India
Fierce Pharma
Friday, October 23, 2009 - 11:24am
tags:
India, Pfizer
Canadian Judge: Zyprexa Is An ‘Almost Invention’
Pharmalot
Friday, October 23, 2009 - 11:21am
tags:
Eli Lilly, Zyprexa, antipsychotics, Canada
Allergan’s First Amendment Case: REMS vs. Off-Label Promotion – and DTC
InVivo
Friday, October 23, 2009 - 5:29am
tags:
off-label, Allergan, DTC, Botox
Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
BNET Pharma
Friday, October 23, 2009 - 5:26am
tags:
FDA, Amgen, Prolia, denosumab
Novo Nordisk Drug Helps Healthy Lose Weight, Cut Blood Pressure
Bloomberg
Friday, October 23, 2009 - 5:25am
tags:
Novo Nordisk, liraglutide
Sepracor CEO in line for $11M golden handshake
Fierce Biotech
Friday, October 23, 2009 - 5:24am
tags:
Sepracor, M&A, Dainippon Sumitomo
EU OKs Merck/Schering-Plough Merger
TheStreet.com
Friday, October 23, 2009 - 5:23am
tags:
Merck, Schering Plough, Europe, M&A
Cost cuts buoy drug groups’ profits
FT.com
Thursday, October 22, 2009 - 7:49pm
tags:
earnings, Merck, Novartis, Schering Plough, Bristol-Myers Squibb
Genzyme: The Gift That Keeps on Giving
Motley Fool
Thursday, October 22, 2009 - 4:30pm
tags:
Genzyme
Unusual Call Activity in Cephalon: Options
TheStreet.com
Thursday, October 22, 2009 - 4:26pm
tags:
Cephalon, options
Good Luck in 2010, Amgen
Motley Fool
Thursday, October 22, 2009 - 4:24pm
tags:
Amgen, earnings, Enbrel, Prolia
Buy! Sell! More Wheeling, Dealing from Bristol-Myers CEO
WSJ Online
Thursday, October 22, 2009 - 4:20pm
tags:
Bristol-Myers Squibb, Pharma CEOs, M&A, Medarex, Jim Cornelius
Eli Lilly Adds Jobs, Plans Cuts
WSJ Online
Thursday, October 22, 2009 - 4:15pm
tags:
Eli Lilly, layoffs, reorganization

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.